Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CUPRIC ANHYDROUS vs CYCLOPENTOLATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CUPRIC ANHYDROUS vs CYCLOPENTOLATE: Safety Overview

Metric CUPRIC ANHYDROUS CYCLOPENTOLATE
Total FAERS Reports 110 576
Deaths Reported 32 10
Death Rate 29.1% 1.7%
Hospitalizations 58 103
Average Patient Age 57.2 yrs 35.5 yrs
% Female Patients 23.2% 51.6%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer Hahnemann Laboratories, INC. Bausch & Lomb Incorporated
Route ORAL OPHTHALMIC
Marketing Status N/A Prescription